Tiziano Scarabelli
Overview
Explore the profile of Tiziano Scarabelli including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
364
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Davidson H, Jain S, Kazdan C, Resnick B, Scarabelli T, Pandya N
J Am Med Dir Assoc
. 2024 Oct;
25(11):105342.
PMID: 39401750
The newly revised Clinical Practice Guideline (CPG) for Diabetes Management in the Post-Acute and Long-Term Care (PALTC) Setting is an extremely useful resource that incorporates new evidence and perspectives related...
2.
Corsetti G, Romano C, Codenotti S, Giugno L, Pasini E, Fanzani A, et al.
Cells
. 2024 Jul;
13(14.
PMID: 39056792
Cancer cells require substantial amounts of energy and substrates for their metabolic hyperactivity, enabling the synthesis of new cells at the expense of healthy ones. Preliminary in vitro data suggest...
3.
Corsetti G, Romano C, Pasini E, Scarabelli T, Chen-Scarabelli C, Dioguardi F
Nutrients
. 2023 May;
15(10).
PMID: 37242170
Background: Doxorubicin (Doxo) is a widely prescribed drug against many malignant cancers. Unfortunately, its utility is limited by its toxicity, in particular a progressive induction of congestive heart failure. Doxo...
4.
Pasini E, Corsetti G, Romano C, Aquilani R, Scarabelli T, Chen-Scarabelli C, et al.
Nutrients
. 2021 Jan;
13(1).
PMID: 33467658
Chronic diseases are characterised by altered autophagy and protein metabolism disarrangement, resulting in sarcopenia, hypoalbuminemia and hypo-haemoglobinaemia. Hypo-haemoglobinaemia is linked to a worse prognosis independent of the target organ affected...
5.
Sternberg M, Pasini E, Chen-Scarabelli C, Corsetti G, Patel H, Linardi D, et al.
Med Sci Monit
. 2019 Sep;
25:7115-7125.
PMID: 31542787
In this systematic review article, we aim to summarize the most up-to-date evidence regarding elevations of cardiac troponin, especially in clinical scenarios other than obstructive coronary artery disease. The accurate...
6.
Chang H, Okwuosa T, Scarabelli T, Moudgil R, Yeh E
J Am Coll Cardiol
. 2017 Nov;
70(20):2552-2565.
PMID: 29145955
In this second part of a 2-part review, we will review cancer or cancer therapy-associated systemic and pulmonary hypertension, QT prolongation, arrhythmias, pericardial disease, and radiation-induced cardiotoxicity. This review is...
7.
Chang H, Moudgil R, Scarabelli T, Okwuosa T, Yeh E
J Am Coll Cardiol
. 2017 Nov;
70(20):2536-2551.
PMID: 29145954
Modern cancer therapy has successfully cured many cancers and converted a terminal illness into a chronic disease. Because cancer patients often have coexisting heart diseases, expert advice from cardiologists will...
8.
Yamaki T, de Haas H, Tahara N, Petrov A, Mohar D, Haider N, et al.
J Nucl Cardiol
. 2017 Aug;
25(1):94-100.
PMID: 28840574
Background: Preclinical studies indicate that minocycline protects against myocardial ischemia/reperfusion injury. In these studies, minocycline was administered before ischemia, which can rarely occur in clinical practice. The current study aimed...
9.
Cardioprotective Utility of Urocortin in Myocardial Ischemia- Reperfusion Injury: Where do We Stand?
Basman C, Agrawal P, Knight R, Saravolatz L, McRee C, Chen-Scarabelli C, et al.
Curr Mol Pharmacol
. 2017 Feb;
11(1):32-38.
PMID: 28228090
Background: There has been a constant pursuit for development of newer therapies which can contribute to the relatively nascent field of cardioprotection in the setting of myocardial ischemiareperfusion injury. One...
10.
Tahara N, Zandbergen H, de Haas H, Petrov A, Pandurangi R, Yamaki T, et al.
Sci Rep
. 2014 Oct;
4:6826.
PMID: 25351258
Acute insult to the myocardium is associated with substantial loss of cardiomyocytes during the process of myocardial infarction. In this setting, apoptosis (programmed cell death) and necrosis may operate on...